Skip to content
2000
Volume 20, Issue 9
  • ISSN: 1871-5273
  • E-ISSN: 1996-3181

Abstract

Alzheimer’s Disease (AD) is characterized by progressive memory loss due to neurodegeneration that occurs mainly during aging. The accumulation of senescent cells has been related to aging. Furthermore, the expression of the variant ApoE ε4 is a critical risk factor for AD. Some events that occur in senescence, such as the secretion of pro-inflammatory molecules, and metabolic and epigenetic changes, in addition to the detection of ApoE4, may accelerate the progression of AD. Here, we discuss the implications of cellular senescence and the ApoE variants in AD. Molecular studies of these risk factors for AD may hence be pivotal to define new biomarkers and novel therapeutic strategies for this neurodegenerative pathology.

Loading

Article metrics loading...

/content/journals/cnsnddt/10.2174/1871527320666210628102721
2021-11-01
2025-10-06
Loading full text...

Full text loading...

/content/journals/cnsnddt/10.2174/1871527320666210628102721
Loading

  • Article Type:
    Review Article
Keyword(s): AD progression; aging; Alzheimer; ApoE; neurodegeneration; senescence
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test